Works matching DE "ANAPLASTIC thyroid cancer"
Results: 1050
Expression of fibroblast growth factor receptor 4 and clinical response to lenvatinib in patients with anaplastic thyroid carcinoma: a pilot study.
- Published in:
- European Journal of Clinical Pharmacology, 2020, v. 76, n. 5, p. 703, doi. 10.1007/s00228-020-02842-y
- By:
- Publication type:
- Article
Comprehensive assessment of atypical and anaplastic pediatric meningiomas utilizing national cancer database: a retrospective cohort study.
- Published in:
- Child's Nervous System, 2024, v. 40, n. 8, p. 2345, doi. 10.1007/s00381-024-06431-7
- By:
- Publication type:
- Article
The use of sodium MRI in the diagnosis of an anaplastic astrocytoma during immunotherapy: a case report.
- Published in:
- Child's Nervous System, 2024, v. 40, n. 3, p. 965, doi. 10.1007/s00381-023-06195-6
- By:
- Publication type:
- Article
Peritoneal metastasis of a brainstem anaplastic ganglioglioma in a 2-year-old boy: case report and literature review.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
A Rare Case of NUT Carcinoma of the Thyroid.
- Published in:
- JCEM Case Reports, 2024, v. 2, n. 3, p. 1, doi. 10.1210/jcemcr/luae037
- By:
- Publication type:
- Article
P-82 Riedel's thyroiditis: three-year follow-up under steroid, rituximab and mycophenolate mofetil treatment.
- Published in:
- JCEM Case Reports, 2024, v. 2, p. 1, doi. 10.1210/jcemcr/luad146.073
- By:
- Publication type:
- Article
Anaplastic Thyroid Carcinoma With Air Spaces.
- Published in:
- JCEM Case Reports, 2024, v. 2, n. 1, p. 1, doi. 10.1210/jcemcr/luad165
- By:
- Publication type:
- Article
An Unexpected Finding of Poorly Differentiated Thyroid Carcinoma in a Toxic Thyroid Nodule.
- Published in:
- JCEM Case Reports, 2023, v. 1, n. 3, p. 1, doi. 10.1210/jcemcr/luad052
- By:
- Publication type:
- Article
Minimally invasive thyroid anaplastic carcinoma with long survival.
- Published in:
- Turkish Journal of Surgery (Turkish Surgical Association), 2018, v. 34, n. 4, p. 319, doi. 10.5152/turkjsurg.2017.3383
- By:
- Publication type:
- Article
Thyroid cancer in the era of endocrine disrupting compounds.
- Published in:
- Archive of Clinical Cases, 2021, v. 8, n. 4, p. 62, doi. 10.22551/2021.33.0804.10188
- By:
- Publication type:
- Article
Morphology and one immunohistochemical marker are enough for diagnosis of primary thyroid angiosarcoma.
- Published in:
- Archive of Clinical Cases, 2021, v. 8, n. 1, p. 7, doi. 10.22551/2021.30.0801.10178
- By:
- Publication type:
- Article
Abstracts for National Conference of Medical Oncology - 19<sup>th</sup> edition.
- Published in:
- Oncolog-Hematolog, 2019, n. 48, p. 36
- Publication type:
- Article
Harnessing Immunity to Treat Advanced Thyroid Cancer.
- Published in:
- Vaccines, 2024, v. 12, n. 1, p. 45, doi. 10.3390/vaccines12010045
- By:
- Publication type:
- Article
Treatment outcome of anaplastic thyroid cancer patients in Vietnam (period 2014-2022).
- Published in:
- European Review for Medical & Pharmacological Sciences, 2024, v. 28, n. 20, p. 4442
- By:
- Publication type:
- Article
CCAT2 contributes to progression and treatment resistance of thyroid carcinoma.
- Published in:
- European Review for Medical & Pharmacological Sciences, 2020, v. 24, n. 23, p. 12224
- By:
- Publication type:
- Article
The function and molecular mechanism of CEP55 in anaplastic thyroid cancer.
- Published in:
- European Review for Medical & Pharmacological Sciences, 2020, v. 24, n. 18, p. 9549
- By:
- Publication type:
- Article
Targeting TGF-β1 and AKT signal on growth and metastasis of anaplastic thyroid cancer cell in vivo.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Targeting TGF-β1 and AKT signal on growth and metastasis of anaplastic thyroid cancer cell in vivo.
- Published in:
- European Review for Medical & Pharmacological Sciences, 2016, v. 20, n. 12, p. 2581
- By:
- Publication type:
- Article
Current Therapeutic Strategies for Glioblastoma.
- Published in:
- 2020
- By:
- Publication type:
- Editorial
Efficacy and safety of pyrotinib combined with albumin‐bound paclitaxel as first‐line treatment for HER2‐positive metastatic breast cancer in patients previously treated with adjuvant and/or neoadjuvant trastuzumab therapy: The stage 1 results of a single‐arm, phase 2 prospective clinical trial
- Published in:
- Clinical & Translational Medicine, 2024, v. 14, n. 5, p. 1, doi. 10.1002/ctm2.1687
- By:
- Publication type:
- Article
The m<sup>5</sup>C methyltransferase NSUN2 promotes codon‐dependent oncogenic translation by stabilising tRNA in anaplastic thyroid cancer.
- Published in:
- Clinical & Translational Medicine, 2023, v. 13, n. 11, p. 1, doi. 10.1002/ctm2.1466
- By:
- Publication type:
- Article
The central role of a two‐way positive feedback pathway in molecular targeted therapies‐mediated pyroptosis in anaplastic thyroid cancer.
- Published in:
- Clinical & Translational Medicine, 2022, v. 12, n. 2, p. 1, doi. 10.1002/ctm2.727
- By:
- Publication type:
- Article
Selective inhibition of DNA ligase IV provides additional efficacy to the treatment of anaplastic thyroid cancer.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1323313
- By:
- Publication type:
- Article
Implant replacement and anaplastic large cell lymphoma associated with breast implants: a quantitative analysis.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1202733
- By:
- Publication type:
- Article
Case Reports: A role of postoperative radiation therapy in completely resected early stage intrathyroid thymic carcinoma: a case report and literature review of the diagnosis and treatment.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1234961
- By:
- Publication type:
- Article
Radiotherapy combined with immunotherapy successfully treated one case of anaplastic thyroid cancer: A case report.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1125226
- By:
- Publication type:
- Article
Case Report: Clinical response to anaplastic lymphoma kinase inhibitor-based targeted therapy in uterine inflammatory myofibroblastic tumor harboring ALK-IGFBP5 fusion.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1147974
- By:
- Publication type:
- Article
Case report: Complete pathological admission in N3 unresectable locally advanced lung adenocarcinoma with a novel INTS10-ALK and EML4-ALK fusion after neoadjuvant crizotinib.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1104910
- By:
- Publication type:
- Article
Immunotherapy or targeted therapy: What will be the future treatment for anaplastic thyroid carcinoma?
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1103147
- By:
- Publication type:
- Article
Case report: Visibly curative effect of dabrafenib and trametinib on advanced thyroid carcinoma in 2 patients.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2022.1099268
- By:
- Publication type:
- Article
Atypical Sweet syndrome: skin sinus tracts in an acutely febrile patient after lymphoma treatment: a case report.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1193808
- By:
- Publication type:
- Article
Case report: Complete response of an anaplastic thyroid carcinoma patient with NRAS Q61R/BRAF D594N mutations to the triplet of dabrafenib, trametinib and PD-1 antibody.
- Published in:
- Frontiers in Immunology, 2023, p. 01, doi. 10.3389/fimmu.2023.1178682
- By:
- Publication type:
- Article
Pembrolizumab in a Patient with Treatment-Naïve Unresectable BRAF-Mutation Negative Anaplastic Thyroid Cancer.
- Published in:
- Case Reports in Endocrinology, 2021, p. 1, doi. 10.1155/2021/5521649
- By:
- Publication type:
- Article
Aggressive Differentiated Thyroid Cancer due to EML4e13-ALKe20 Fusion: A Case Presentation and Review of the Literature.
- Published in:
- Case Reports in Endocrinology, 2021, p. 1, doi. 10.1155/2021/8837399
- By:
- Publication type:
- Article
Three Cases of Anaplastic Thyroid Carcinoma Transformation and Leukocytosis during Lenvatinib Treatment.
- Published in:
- Case Reports in Endocrinology, 2020, p. 1, doi. 10.1155/2020/6667237
- By:
- Publication type:
- Article
A Rare Case of Uterine Leiomyosarcoma with Metastasis to the Thyroid Gland.
- Published in:
- Case Reports in Endocrinology, 2020, p. 1, doi. 10.1155/2020/8889843
- By:
- Publication type:
- Article
Dramatic Response to First Line Single Agent Pembrolizumab in Anaplastic Thyroid Carcinoma.
- Published in:
- Case Reports in Endocrinology, 2019, p. 1, doi. 10.1155/2019/9095753
- By:
- Publication type:
- Article
The Utility of Immunohistochemistry in Differentiating Metastatic Primary Squamous Cell Carcinoma of the Thyroid from a Primary Lung Squamous Cell Carcinoma.
- Published in:
- Case Reports in Endocrinology, 2019, p. 1, doi. 10.1155/2019/8641267
- By:
- Publication type:
- Article
Remarkable Presentation: Anaplastic Thyroid Carcinoma Arising from Chronic Hyperthyroidism.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
A Case of Pneumothorax after Treatment with Lenvatinib for Anaplastic Thyroid Cancer with Lung Metastasis.
- Published in:
- Case Reports in Endocrinology, 2018, p. 1, doi. 10.1155/2018/7875929
- By:
- Publication type:
- Article
Differentiated and anaplastic thyroid carcinoma: Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual.
- Published in:
- CA: A Cancer Journal for Clinicians, 2018, v. 68, n. 1, p. 55, doi. 10.3322/caac.21439
- By:
- Publication type:
- Article
35th Anniversary of Thyroid—Journal of the American Thyroid Association.
- Published in:
- Thyroid, 2025, v. 35, n. 1, p. 1, doi. 10.1089/thy.2024.0739
- By:
- Publication type:
- Article
High Prevalence of TBC1D12 5′UTR Mutations in Anaplastic Thyroid Cancer.
- Published in:
- 2025
- By:
- Publication type:
- Letter
The Cancer-Specific Health Economic Measure QLU-C10D is Valid and Responsive for Assessing Health Utility in Patients with Thyroid Cancer.
- Published in:
- Thyroid, 2024, v. 34, n. 11, p. 1356, doi. 10.1089/thy.2024.0396
- By:
- Publication type:
- Article
Macrophage-Induced Carboxypeptidase A4 Promotes the Progression of Anaplastic Thyroid Cancer.
- Published in:
- Thyroid, 2024, v. 34, n. 9, p. 1150, doi. 10.1089/thy.2023.0427
- By:
- Publication type:
- Article
Preview of the 93rd American Thyroid Association Annual Meeting.
- Published in:
- Thyroid, 2024, v. 34, n. 7, p. 807, doi. 10.1089/thy.2024.0185
- By:
- Publication type:
- Article
Neoadjuvant Treatment of Locally Advanced Thyroid Cancer: A Preliminary Latin American Experience.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Alginate/Carboxymethyl Chitosan Core-Shell Microspheres Coloaded with Doxorubicin/Docetaxel Reverse Chemotherapy Resistance in Anaplastic Thyroid Carcinoma.
- Published in:
- Thyroid, 2024, v. 34, n. 7, p. 856, doi. 10.1089/thy.2024.0023
- By:
- Publication type:
- Article
Rural-Urban Disparities in the Continuum of Thyroid Cancer Care: Analysis of 92,794 Cases.
- Published in:
- Thyroid, 2024, v. 34, n. 5, p. 635, doi. 10.1089/thy.2023.0357
- By:
- Publication type:
- Article
Checkpoint Inhibition in Addition to Dabrafenib/Trametinib for BRAF<sup>V600E</sup>-Mutated Anaplastic Thyroid Carcinoma.
- Published in:
- Thyroid, 2024, v. 34, n. 3, p. 336, doi. 10.1089/thy.2023.0573
- By:
- Publication type:
- Article